Polymer Nanofiber Applications in Cancer Wound Healing
Advances, Challenges, and Future Directions
- 1st Edition - September 1, 2026
- Latest edition
- Editors: Arun Kumar Singh, Mahesh Narayan, Meenakshi Dhanawat, Rajwinder Kaur, Nimisha Srivastava
- Language: English
Polymer Nanofiber Applications in Cancer Wound Healing: Advances, Challenges, and Future Directions explores the use of nanoscale polymeric fibers for targeted cancer therap… Read more
- Details the characteristics, properties, and processing of polymer nanofiber biomaterials for cancer wound healing and repair
- Reviews traditional and novel treatments in cancer therapy, including topical therapeutics and personalized medicines
- Explores the use of AI in nanofiber technology
- Assesses clinical trials and patents for polymer nanofiber-based cancer treatments, as well as production and commercialization challenges
2. Nanofibers for Transdermal Delivery in Cancer Wound Healing Therapy
3. Nano-Fiber Delivery Systems in Cancer Wound Treatment and Skin Regeneration
4. Biopolymer-Based Electrospun Nanofiber Membranes for Tumor Wound Healing
5. Electrospun Fibers in Cancer Wound Healing and Tissue Regeneration
6. Nanofibers in Topical Therapeutics for Cancer Therapy
7. Nanofiber Technology for Therapeutic Delivery in Cancer Wound Healing
8. Nanofiber-based Platforms for Cancer Diagnosis and Treatment
9. Artificial Intelligence Applications in Cancer Wound Healing and Nanofiber Technology
10. Nanotechnology in Cancer Wound Healing: Innovations and Future Prospects
11. Nanofibers as Personalized Medicine: Future Frontiers
12. Current Status of Clinical Trials and Patents
13. Scalability and Production Challenges of Polymeric Nanofibers
14. Regulatory Considerations for Polymeric Nanofibers: A Global Perspective
- Edition: 1
- Latest edition
- Published: September 1, 2026
- Language: English
AS
Arun Kumar Singh
MN
Mahesh Narayan
MD
Meenakshi Dhanawat
Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with over 18 years of experience in pharmaceutical sciences. She holds a Master’s degree from NIPER Mohali and a PhD from IIT-BHU Varanasi, specializing in medicinal chemistry and CNS drug delivery targeting 5HT1A/2A receptors. Dr. Dhanawat’s research spans targeted therapies like JAK-STAT inhibitors, signaling pathways in health and disease, synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, and herbal drug extraction. She has published 75 research articles and reviews, holds 5 patents, authored 6 books, contributed 13 book chapters, and edited 5 books. An active participant in national and international conferences, she has received prestigious grants from AAPS, DBT, and DST, along with the Rajiv Gandhi National Fellowship. Dr. Dhanawat’s work significantly advances pharmaceutical innovation and education, reflecting her commitment to scientific excellence and mentorship.
RK
Rajwinder Kaur
NS